• Home
• About Us
• Aesthetic Medicine Training
  • Botox Training
  • Hands-On Botox and Dermal Filler Training
  • MedSpa / Aesthetic Practice Business Traininig
• Resources
  • Magazines and Periodicals
  • More Resources
  • Associations
  • Events
  • Archives
• Consumer Information

Subscribe

Triumph for Drug to Straighten Clenched Fingers

Auxilium and BioSpecifics hope that the half-century-old collagenase might eventually become as versatile as Botox, another bacterial product. They are looking at uses that range from loosening up immobile “frozen shoulders” to eliminating fat bulges and cellulite.

It took half a century. But a tiny drug maker on Long Island has finally found a potentially lucrative use for its only medicine: straightening clenched fingers.

The Food and Drug Administration approved the drug, known as Xiaflex, last month as a nonsurgical treatment for Dupuytren’s contracture, a condition in which one or more fingers cannot be straightened.

Hundreds of thousands of Americans have Dupuytren’s, which can make it difficult to type, shake hands, wear gloves, reach into a pocket or perform numerous other tasks. The afflicted have included Ronald Reagan, Margaret Thatcher, the playwright Samuel Beckett and the classical pianist Misha Dichter.

Xiaflex, an injectable drug that goes on sale later this month, will not be cheap, at an estimated average cost per course of treatment of $5,400. But analysts expect sales to reach hundreds of millions of dollars a year. Read more

               

IAPAM Announces Strong Growth in Botox and Weight Loss

The IAPAM predicts strong growth in cosmetic injectables and hCG medical weight management programs for 2010.  Physicians who incorporate these aesthetic procedures into their practices, will reap significant profit in 2010.  The IAPAM’s goal is to provide industry-leading, practical education for physicians by offering the field’s most comprehensive, hands-on, aesthetic training, including: the Aesthetic Medicine Symposium, The IAPAM’s Exclusive Physician (hCG) Medical Weight Management Training, Botox Training, Dermal Filler Training, Advanced Filler Training, and Chemical Peel Training.
 
In the recently published American Society for Aesthetic Plastic Surgery’s 2009 Statistics, the ASAPS has found that of the 10 million cosmetic procedures completed in the US in 2009, 85% of these procedures were non-invasive.  Moreover, while surgical procedures, like eyelid surgery, rhinoplasty and breast augmentations decreased by 17% from 2008 to 2009, non-surgical procedures, lead by cosmetic injectables and laser treatments, increased by 1%. 

Jeff Russell, Executive Director of the International Association for Physicians in Aesthetic Medicine, offer his analysis on the ASAPS 2009 Procedure Statistics.  “As supported by the ASAPS 2009 numbers, it appears that people, influenced by this economy, are putting more invasive procedures like facelifts on hold.  Such cosmetic surgical options are down 28.9%. Conversely, more economical ‘liquid facelifts,’ using botulinum toxin products (Botox & Dysport) and dermal fillers, have grown significantly in popularity,” reflects Russell.  This growth in non-invasive treatment continues from the previous year. 

Moreover, Jeff Russell has seen a similar growth in “physicians adding hCG medical weight loss programs to their practices.” To assist physicians, the IAPAM has launched a new medically supervised weight management training program for doctors and other healthcare professionals.  “Our new Medical Weight Management with hCG has garnered great praise from the physicians who have attended,”  shares Russell.  He also sees the benefits in offering complementary medical weight management and aesthetic medicine treatments to patients.   “The next breakthrough will be in laser assisted lipolysis. These procedures have developed to the point where they can be done under local anesthetic in a doctors office.”  Laser liposuction paired with medical weight management will be a key growth area for physicians in 2010.

To position themselves to capture this market growth, over 600 physicians, as well as their accompanying medspa managers, registered nurses, and assistants, have attended the IAPAM’s training programs. 

Upcoming 2010 educational opportunities

The IAPAM’s Aesthetic Medicine Symposiums in Scottsdale, Arizona:

March 27-29, 2010;
April 24-26, 2010; and
June 5-7, 2010.  

The IAPAM’s Exclusive Physician hCG Weight Management Training, in Scottsdale, Arizona:

March 26, 2010;
April 23, 2010; and
June 4, 2010.

Doctors who have attended IAPAM training, testify to the comprehensiveness of the programs and rave that, “the support you get from the IAPAM afterwards definitely makes their courses different than the others.” Indeed, the benefits from attending an IAPAM Educational Event, and membership in the IAPAM, endure beyond the training. 

Moreover, the new hCG training has received a resounding endorsement from registrants.  “I wasn’t sure if coming tothe IAPAM’s weight loss presentation would be worth it, given the flight cost, hotel etc., but it definitely was,” says a physician from Pennsylvania after completing February’s hCG / Physician Weight Loss Training.

For additional information and to register for an upcoming training session, please contact Jeff Russell, Executive Director, IAPAM, at 1-800-219-5108 ext. 705, or visit http://www.iapam.com or http://www.aestheticmedicinesymposium.com or http://www.aestheticmedicinesymposium.com/physician-hcg-weight-loss-training.

About the International Association for Physicians in Aesthetic Medicine (IAPAM)
 
The International Association for Physicians in Aesthetic Medicine is a voluntary association of physicians and supporters, which sets standards for the aesthetic medical profession. The goal of the association is to offer education, ethical standards, credentialing, and member benefits. IAPAM membership is open to all licensed medical doctors (MDs) and doctors of osteopathic medicine (DOs). Information about the association,
or about physician certification, can be accessed through the IAPAM’s website http://www.iapam.com or by contacting:
 
Jeff Russell, Executive-Director
International Association for Physicians in Aesthetic Medicine (IAPAM)
1-800-219-5108 x705
e-mail: info@theiapam.com
web: http://www.IAPAM.com

Websites
Facebook:  http://www.facebook.com/IAPAM
Twitter:  http://www.twitter.com/IAPAM
IAPAM’s Aesthetic Medicine News:  http://www.aestheticmedicinenews.com
Become a fan of the IAPAM’s hCG Group on Facebook:  http://www.facebook.com/hCGWeightLoss

Watch a preview of IAPAM’s Aesthetic Medicine Symposium at http://www.youtube.com/watch?v=Of-jMxVNLOY
Watch a preview of the IAPAM’s Botox Training Program at http://www.youtube.com/watch?v=Mc6XkuFOHrw

               

Almost Half of Americans Approve of Cosmetic Plastic Surgery Regardless of Income

A new survey shows that almost half (48%) of all Americans regardless of income approve of cosmetic plastic surgery and almost a quarter would consider cosmetic surgery for themselves. According to the February 2010 report, 48% of respondents with an income of under $25K approve of cosmetic surgery (52% of respondents with an income between $25K-$50K approve, 55% of respondents with an income between $50K-$75K approve, and 62% of respondents with an income above $75K approve) and 23% of the respondents who earn under $25K would consider cosmetic surgery for themselves.    

“Twenty years ago people thought only movie stars and rich women had plastic surgery; now people in every income bracket know someone who has had a plastic surgery procedure or would consider plastic surgery for themselves. Even in this difficult economic time, people are willing to invest in the things that improve their quality of life,” said Renato Saltz, MD, President of The American Society for Aesthetic Plastic Surgery (ASAPS). “Feeling good about the way they look is high on the list of priorities for many Americans.”  Read more

               

Despite Recession, Overall Plastic Surgery Demand Drops Only 2 Percent From Last Year

American Society for Aesthetic Plastic Surgery reports almost 10 Million Cosmetic Procedures in 2009

Almost 10 million cosmetic surgical and nonsurgical procedures were performed in the United States in 2009, according to statistics released today by the American Society for Aesthetic Plastic Surgery.  The Aesthetic Society, which has collected multi-specialty procedural statistics since 1997, says the overall number of cosmetic procedures has increased 147 percent since the tracking of the statistics first began. The most frequently performed nonsurgical procedure was injections of Botulinum Toxin Type A (including Botox and Dysport) and the most popular surgical procedure was breast augmentation.

“Plastic surgery is feeling the effects of the recession, just like many other sectors of the marketplace,” said Renato Saltz, MD, Aesthetic Society President. “However, repeat patients and those putting off surgery, are likely the reason for the small growth in non-surgical cosmetic  procedures. Growth in demand will likely return as the recession eases and baby boomer’s offspring begin to explore surgical options.”  Read more

               

Body Shaping Companies Announce Co-Marketing and Sales Alliance at American Academy of Dermatology

Eleme Medical Inc. and Osyris Medical USA announced today that they have entered into a strategic co-marketing alliance.  The companies will be collaborating on specific marketing, public relations and trade show events to target dermatologists, plastic surgeons and medical spas. A recent MEDACorp survey of dermatologists and plastic surgeons showed that laser lipolysis and cellulite devices were the categories that most interested physicians who planned to purchase an AED device in 2010.* Under terms of the agreement Osyris USA, who currently sells the laser lipolysis device Lipotherme™, will be added to the current distribution network in the U.S. for products from Eleme Medical including the SmoothShapes® system. Additionally, Eleme Medical will provide certain sales support on certain Osyris product offerings, including Lipotherme.

Nancy Briefs, President and CEO of Eleme Medical, commented, “Osyris and Eleme Medical are premier aesthetic companies focused specifically on the body shaping segment. The addition of Osyris to the company’s existing distribution network will provide greater geographic coverage in the United States. Combining the expertise of both teams is a strategic move to serve our physician partners more completely and increase revenues by offering one stop shopping for body shaping technologies that grow practices.” Read more

               

Palomar Medical Presents New Aesthetic Products at the American Academy of Dermatology Annual Meeting

Palomar Medical Technologies, Inc., a leading researcher and developer of light-based systems for cosmetic treatments, announced today that it will preview two new products — the Artisan(TM) Aesthetic System and the MaxG(TM) pulsed light handpiece — at the 68th Annual Meeting of the American Academy of Dermatology (AAD) in Miami, Florida, from March 5th through March 9th.

The new Artisan Aesthetic System offers key skin resurfacing and skin rejuvenation technologies — a fractional non-ablative laser for treating acne and surgical scars, melasma, and striae; a fractional ablative laser for resurfacing and wrinkle treatment; and a pulsed light device for treatment of pigmented and vascular lesions — in one comprehensive system perfect for skin rejuvenation and anti-aging practices. Artisan empowers aesthetic practitioners with the ability to treat each discrete sign of aging and other undesirable skin conditions using the most appropriate technology. With Artisan, practitioners can tailor unique treatment regimens to each client’s specific needs, offering the best aesthetic outcome with the least amount of downtime or disruption. The Artisan Aesthetic System is pending US FDA clearance, and Palomar will begin shipments upon clearance. Read more

               

BOTOX for Acne

Acne is a condition that leads to breakouts of skin lesions, commonly called pimples. Although the exact cause isn’t known, it’s believed to occur from a combination of factors: excess oil production (sebum), clogged pores, bacteria and inflammation. Excess oil, dirt, hair and skin cells accumulate in the follicle and clog the pore. Bacteria on the skin thrive in this mixture, causing inflammation and the development of pimples.

There are several types of acne lesions. Pore blockage close to the surface of the skin causes minor inflammation and the development of a comedo. A closed comedo, or whitehead, is caused by a blocked or narrowed opening into the follicle. An open comedo, or blackhead, looks black or discolored because the surface of the plug is dark. A papule is a solid lesion that causes a small bump on the surface of the skin. It occurs when inflammation is a bit deeper. Even deeper inflammation causes the formation of a pustule, a dome shaped lesion filled with pus. Deep blockage and inflammation leads to the most serious types of acne lesions, nodules and cysts. A nodule is a painful, solid, dome-shaped pimple that extends deep into the skin. A cyst is a deep, painful, pus-filled pimple that is severely inflamed. Both nodules and cysts can lead to significant scarring.

Acne is a very common skin condition that typically appears between 10 and 13. According to the American Academy of Dermatology, nearly 100 percent of teens have at least an occasional acne breakout. For most people, the symptoms last about five to ten years. The most common sites of acne lesions are the face, neck, chest, shoulders, scalp, upper arms and legs. Read more

               

Medicis Presents the Dysport(TM) Challenge: Love It or Leave It

Medicis (NYSE:MRX) today announced the launch of its new program, the “Dysport Challenge.” Approved by the U.S. Food and Drug Administration (FDA) in April 2009, Dysport (abobotulinumtoxinA) is a prescription injection used to temporarily improve the look of moderate to severe frown lines between the eyebrows (glabellar lines) in adults less than 65 years of age.

“We continue to be pleased with the positive feedback from physicians and patients who are using Dysport,” said Jonah Shacknai, Chairman and Chief Executive Officer of Medicis. ”We are so confident patients will love Dysport that we are introducing the Dysport Challenge. Patients may try Dysport and save $75.  If they love it, they may receive $75 off their next Dysport treatment for a total savings of $150.  Patients who do not love their Dysport treatment can have their frown lines treated with another botulinum toxin type A product and receive a $75 rebate.” 

The Dysport Challenge runs from March 1 through April 30, 2010. Offer terms and conditions apply. For complete offer details, please see below, visit www.DysportUSA.com or talk to your licensed healthcare professional.  Ask your healthcare professional if Dysport is right for you. Read more

               

Allergan Celebrates 20 Years of Approved Use of Botulinum Toxin Type A (BOTOX(R)) in Canada

Twenty years ago, the first approved use of BOTOX(R) (botulinum toxin type A), a neurotoxin widely used to treat several life altering medical conditions, was granted in Canada. As part of the 20th anniversary celebrations, healthcare professionals from coast to coast reflect upon the discovery, science and evolution of a therapy that has impacted the lives of millions of patients worldwide.

BOTOX(R), a purified protein derived from the naturally-occurring bacterium Clostridium botulinum, was first approved by Health Canada on March 14th,1990 for the treatment of strabismus (crossed eyes), blepharospasm (uncontrollable blinking), and VII nerve disorder.(1) Other approvals for the medical uses of BOTOX(R) soon followed and included:

–  To reduce the subjective symptoms and objective signs of cervical
    dystonia (muscle contractions in the neck) on March 29th, 1995;
–  For the treatment of dynamic equinus foot deformity due to spasticity in
    pediatric cerebral palsy in patients two years of age or older on July
    7th, 1999;
–  For the treatment of hyperhidrosis of the axilla (excessive underarm
    sweating) on August 31st, 2001; and
–  In the management of focal spasticity (muscle tightness that can affect
    multiple areas of the body) on October 24th, 2001.(1) Read more

               

IAPAM Reports on the Best Practices for the use of hCG in Weight Loss

The IAPAM is committed to educating physicians in the industry’s best practices for medical weight loss management. In support of this commitment, the IAPAM has completed a survey of several experts in the use of hCG in a medically supervised weight loss program. These experts agree that there are 3 keys to successfully incorporating hCG into a physician-managed weight loss protocol:  strict adherence to the protocol and physician supervision, properly sourced hCG, and comprehensive hCG protocol training.

Following a survey of several experts in the use of hCG in medically supervised weight loss program, the IAPAM has determined that there are 3 critical success factors that must be adhered to, to ensure that an hCG program is successful for both the patient and the doctor.  These key elements to success are: 

1.  Patients must follow the protocol precisely and patients should be under a physician’s care, so that possible side effects can be understood and managed;

2.  hCG must be sourced from an experienced physician or accredited compounding pharmacy; and

3.  Training is essential to ensure that the managing physician: has a comprehensive understanding of the hCG protocol, including past and current research, understands the effects of medication and/or the use of vitamins in the protocol, has access to a variety of 500 cal/day recipes, and other nuances of the protocol that ensure success for the patient. Read more

               

Next Page »

IAPAM Aesthetic Medicine Resources

• Recent News

  • Triumph for Drug to Straighten Clenched Fingers
  • IAPAM Announces Strong Growth in Botox and Weight Loss
  • Almost Half of Americans Approve of Cosmetic Plastic Surgery Regardless of Income
  • Despite Recession, Overall Plastic Surgery Demand Drops Only 2 Percent From Last Year
  • Body Shaping Companies Announce Co-Marketing and Sales Alliance at American Academy of Dermatology
  • Palomar Medical Presents New Aesthetic Products at the American Academy of Dermatology Annual Meeting
  • BOTOX for Acne
  • Medicis Presents the Dysport(TM) Challenge: Love It or Leave It
  • Allergan Celebrates 20 Years of Approved Use of Botulinum Toxin Type A (BOTOX(R)) in Canada
  • IAPAM Reports on the Best Practices for the use of hCG in Weight Loss

Copyright © 2009 Aesthetic Medicine News · Sitemap · Privacy Policy & Terms of Use · Login